LDLR and kidney disorder: PCSK9 and the liver tissue inducible degrader of the LDL receptor (IDOL) are increased in this specific kidney disease and together determine an important LDL receptor deficiency, a decreased hepatic uptake of LDL and consequently increased LDL cholesterol plasma levels [79].